Skip to content

Ashland ASH Pre-tax stock-based compensation cost

Pre-tax stock-based compensation cost at other companies

Innospec logo
InnospecIOSP
Ingredion logo
IngredionINGR
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$482.0M+0.6%
Gross profit$147.0M0.0%
Operating income$39.0M-23.5%
Net income$16.0M-48.4%
EPS (diluted)$0.34-47.7%

Balance sheet

See full
Cash & equivalents$343.0M+104%
Total debt$1.5B-0.6%
Total equity$1.9B-27.1%
Total assets$4.5B-14.0%

Cash flow

See full
Operating cash flow$50.0M+456%
CapEx$17.0M-19.0%
Free cash flow$33.0M+375%

Valuation

See full
Market cap$2.93B-9.0%
Enterprise value$4.06B-10.6%
P/S1.6×0.0×

Profitability

See full
Gross margin30%-1.7pp
Operating margin-37.3%
Net margin-40.8%-48.8pp
FCF margin13.6%+9.7pp

Returns & leverage

See full
Return on equity-33.4%-38.5pp
Debt / equity0.8×+0.2×
Current ratio3.1×+0.7×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: Ashland’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ashland's pre-tax stock-based compensation cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ashland's pre-tax stock-based compensation cost?
Ashland (ASH) reported pre-tax stock-based compensation cost of $5M in Q1 2026.
How has Ashland's pre-tax stock-based compensation cost changed year-over-year?
Ashland's pre-tax stock-based compensation cost decreased by 0.0% year-over-year, from $5M to $5M.
What is the long-term trend for Ashland's pre-tax stock-based compensation cost?
Over 4 years (2021 to 2025), Ashland's pre-tax stock-based compensation cost has grown at a -6.1% compound annual growth rate (CAGR), from $18M to $14M.